This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...

1Department of Molecular Biology, Princeton University, Princeton, New Jersey. 2Ludwig Institute for Cancer Research Princeton Branch, Princeton, New Jersey.

Cancer Res (2025) 85 (1): 183–188. The Cancer Research editors wish to acknowledge with sincere appreciation the assistance of the following reviewers who have generously contributed their time and ...

Glutathione S-Transferase P (GSTP) known as a Phase II detoxification enzyme has more recently been identified as a modulator of MAP kinase-related cell-signaling pathways. It is known to be ...

Basic and translational research shows that a low-carbohydrate, high-fat ketogenic diet, which is rich in the metabolite β-hydroxybutyrate, can increase the proliferation of chimeric antigen receptor ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

In a phase II trial, the ROR1-targeting antibody–drug conjugate zilovertamab vedotin led to a complete response in nearly 100% of patients with diffuse large B-cell lymphoma.

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

Major Finding: Tumor-connected neurons promote glioblastoma growth, invasion, and resistance to radiotherapy. Concept: Rabies virus–based retrograde tracing of neurons reveals their integration with ...

Bristol Myers Squibb announced that the FDA approved nivolumab and hyaluronidase (Opdivo Qvantig) for subcutaneous injection across all currently approved solid tumor indications for intravenous (IV) ...